Squarepoint Ops LLC Atara Biotherapeutics, Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $51,310 - $103,989	-34,207 Reduced 32.03%	72,574 $116,000
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $184,889 - $360,534	66,032 Added 162.05%	106,781 $309,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $464,963 - $845,091	-163,145 Reduced 80.01%	40,749 $133,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $581,097 - $1.78 Million	203,894 New	203,894 $771,000
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $1.53 Million - $1.97 Million	-118,848 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $733,320 - $1.09 Million	52,380 Added 78.8%	118,848 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $139,876 - $289,579	11,040 Added 19.92%	66,468 $1.31 Million
Q3 2020 Nov 16, 2020	SELL	$11.92 - $15.87 $1.01 Million - $1.34 Million	-84,609 Reduced 60.42%	55,428 $718,000
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $759,513 - $1.51 Million	100,865 Added 257.49%	140,037 $2.04 Million
Q1 2020 May 15, 2020	BUY	$5.69 - $17.78 $121,783 - $380,545	21,403 Added 120.45%	39,172 $333,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $77,950 - $120,182	-7,158 Reduced 28.72%	17,769 $293,000
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $299,871 - $497,044	24,927 New	24,927 $352,000
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $552,011 - $1.19 Million	-28,977 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $356,107 - $523,377	12,539 Added 76.28%	28,977 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $227,485 - $316,345	-7,362 Reduced 30.93%	16,438 $571,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $406,579 - $504,600	-11,600 Reduced 32.77%	23,800 $984,000
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $850,630 - $1.25 Million	24,200 Added 216.07%	35,400 $1.3 Million
Q1 2018 May 15, 2018	SELL	$18.0 - $48.35 $166,680 - $447,721	-9,260 Reduced 45.26%	11,200 $437,000
Q4 2017 Feb 14, 2018	BUY	$13.2 - $18.1 $270,072 - $370,326	20,460	20,460 $370,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$86.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$78.7 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$58.1 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$55.9 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$55.4 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $802M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account